I ran the stock screener for foreign stocks traded in the NYSE with the following conditions:

Market Cap = $100B+

Dividend Yield = 3% or more

The search resulted in the following 10 ADRs:

1. Royal Dutch Shell plc ( RDS.A)

2. China Mobile Ltd. (CHL)

3. BP plc (BP)

4. TOTAL S.A. (TOT)

5. Telefonica S.A. (TEF)

6. Banco Santander, S.A. (STD)

7. Vodafone Group Plc (VOD)

8. Novartis AG (NVS)

9. GlaxoSmithKline plc (GSK)

10. Sanofi-Aventis SA (SNY)

Oil giants Royal Dutch Shell plc ( RDS.A), BP plc (BP) and TOTAL S.A. (TOT) have diversified global operations. With the price oil rising near $80, this sector is getting the attention of investors. Yesterday BP reported strong earnings. Total and Shell may follow suit as well.

Telecom providers China Mobile Ltd. (CHL), Telefonica S.A. (TEF) and Vodafone Group Plc (VOD) all have excellent franshises. For example, UK-based Vodafone has established its brand in many emerging markets and continues to increase subscribers.

Spanish bank Banco Santander, S.A. (STD) is the lone bank in the above list. Despite sluggish domestic housing market, Santander is well positioned for growth due its huge presence in overseas markets such as Latin America.

Drug majors Novartis AG (NVS), GlaxoSmithKline plc (GSK) and Sanofi-Aventis SA (SNY) manufacture many preventive vaccines, medicines and consumer health-care products. These drug makers have diversified businesses and their stocks are good picks for all market conditions. Last year all three had revenues exceeding $40B. GlaxoSmithKline plc is especially well known in developing countries. Some of the top brands of GlaxoSmithKline include Ribena, Horlicks, Aquafresh, Panadol and Tums. GSK website states “Every minute…more than 1,100 prescriptions are written for GSK products.”